[Questions and answers on the role of azathioprine and 6-mercaptopurine in the treatment of inflammatory bowel disease]

MeSH terms

• Adult
• Anti-Inflammatory Agents, Non-Steroidal / administration & dosage
• Anti-Inflammatory Agents, Non-Steroidal / therapeutic use
• Azathioprine / administration & dosage
• Azathioprine / adverse effects
• Azathioprine / therapeutic use*
• Chi-Square Distribution
• Child
• Colitis, Ulcerative / complications
• Colitis, Ulcerative / drug therapy
• Colitis, Ulcerative / surgery
• Confidence Intervals
• Crohn Disease / complications
• Crohn Disease / drug therapy
• Crohn Disease / surgery
• Female
• Humans
• Immunosuppressive Agents / administration & dosage
• Immunosuppressive Agents / adverse effects
• Immunosuppressive Agents / therapeutic use*
• Infant, Newborn
• Inflammatory Bowel Diseases / complications
• Inflammatory Bowel Diseases / drug therapy*
• Inflammatory Bowel Diseases / surgery
• Injections, Intravenous
• Intestinal Fistula / drug therapy
• Intestinal Fistula / etiology
• Male
• Mercaptopurine / administration & dosage
• Mercaptopurine / adverse effects
• Mercaptopurine / therapeutic use*
• Mesalamine / administration & dosage
• Mesalamine / therapeutic use
• Meta-Analysis as Topic
• Odds Ratio
• Placebos
• Pregnancy
• Pregnancy Complications / drug therapy
• Randomized Controlled Trials as Topic
• Recurrence
• Time Factors